Clinical Trial Detail

NCT ID NCT04066491
Title Gemcitabine Plus Cisplatin With or Without M7824 in Participants With 1L Biliary Tract Cancer (BTC)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications

biliary tract cancer

Therapies

Cisplatin + Gemcitabine

Cisplatin + Gemcitabine + M7824

Age Groups: adult senior

No variant requirements are available.